BTIG Reiterates Buy on Jade Biosciences, Maintains $77 Price Target

Benzinga · 2d ago
BTIG analyst Julian Harrison reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $77 price target.